Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Merger unites Sernova's Cell Pouch Bio-hybrid Organ with Seraxis' stem cell-derived pancreatic islet cells and in-house cGMP manufacturingThe combined entity will operate under the name BetaNSR-02 ...
Yahoo Finance

Obsidian, Galera to advance cell therapy following reverse merger

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
RTTNews

Sernova Biotherapeutics And Seraxis Holdings Agree To Merge To Form BetaNova Biotherapeutics

Sernova Biotherapeutics Inc. ( SVA.TO, SEOVF) and Seraxis Holdings, Inc. announced Tuesday a definitive agreement to combine their technologies and businesses to create a clinical-stage company, ...
Nasdaq

Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases

PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly ...
Nasdaq

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

FULLERTON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, today ...
Pulse 2.0

Candid Therapeutics: $505 Million Financing And Merger With Rallybio To Advance Autoimmune T-Cell Engager Pipeline

Rallybio Corporation announced a merger agreement with clinical-stage biotechnology company Candid Therapeutics, a deal that will create a combined company focused on developing T cell engager ...